Korean J Helicobacter  Up Gastrointest Res Search

CLOSE


Korean J Helicobacter  Up Gastrointest Res > Volume 16(4); 2016 > Article
The Korean Journal of Helicobacter  and Upper Gastrointestinal Research 2016;16(4):185-188.
DOI: https://doi.org/10.7704/kjhugr.2016.16.4.185    Published online December 10, 2016.
Guidance for Endoscopic Procedures in Patients Taking Novel Oral Anticoagulants
Kyoung Oh Kim
Department of Internal Medicine, Gachon University College of Medicine, Incheon, Korea. kkoimge@naver.com
내시경 시술 시 고려사항(길잡이): Novel Oral Anticoagulants 복용 중인 환자에서
김경오
가천대학교 의과대학 내과학교실
Received: 21 November 2016   • Accepted: 8 December 2016
Abstract
Anticoagulant agents are used to reduce the risk of thromboembolic complications in patients with atrial fibrillation or deep vein thrombosis. Several new generation of oral anticoagulants have been approved. These novel oral anticoagulants (NOACs) include direct thrombin inhibitors, dabigatra etexilate, and the direct factor Xa inhibitors, rivaroxaban, apixaban and edoxaban. This review evaluates NOACs-related gastrointestinal bleeding and summarizes the ideal management strategies based on the guideline suggested by American Society for Gastrointestinal Endoscopy.
Key Words: Anticoagulants; Endoscopy; Gastrointestinal hemorrhage; Thromboembolism


ABOUT
BROWSE ARTICLES
EDITORIAL POLICY
FOR AUTHORS
FOR REVIEWERS
Editorial Office
Lotte Gold Rose II Room 917, 31 Seolleung-ro 86-gil, Gangnam-gu, Seoul 06193, Korea
Tel: +82-2-565-9946    Fax: +82-2-565-9947    E-mail: hpylori@kams.or.kr                

Copyright © 2022 by Korean College of Helicobacter and Upper Gastrointestinal Research.

Developed in M2PI

Close layer
prev next